Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Immunovia Publishes Interim Report Jan-Sep 2022

July-September 2022 · Net sales amount KSEK 358 (377) divided by sales of tests KSEK 111 and royalties KSEK 247. · Net earnings amount MSEK -23 (-36) and earnings per share before and after dilution were SEK – 1.01 (-1.60) · Cash Flow from operating activities amount MSEK -37 (-38). · Cash and equivalents at the end of the period amounted to MSEK 159 (339). · On July 5 the Company informed that a CPT PLA Code for the IMMray™ PanCan-d test was approved from the American Medical Association (AMA). The code will be effective from October 1, 2022. · On August 11 the Company

LifeClean has Developed a Revolutionary Method for PFAS Removal

LifeClean International AB (publ) (“the Company”) announces today that the Company has developed an effective method for removing PFAS substances ("PFAS") from fire-fighting foam tanks. PFAS are environmentally and health-damaging substances previously used on a large scale as an ingredient in, e.g., fire-fighting foams. The phase-out of PFAS is ongoing and global, which opens up a significant market potential for the Company. Successful customer tests of LifeClean's method have already been conducted.The LifeClean group, under the leadership of Chairman and founder Ragnar Krefting, has

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q3 2022

During the third quarter, our first major deliveries to Duni commenced, which resulted in good growth for the Nonwoven & technical textiles business unit. The Functional wood and Green coatings & maintenance products business units are now noticing an impact from the deteriorated hardware market, with a fall-off in sales. Overall, the Group’s sales decreased by -1.7 (13.5) percent to SEK MSEK 22.3 (22.6). By contrast, cash flow from operating activites strengthened considerably to MSEK 3.5 (-0.2) thanks to reduced inventory levels.Translation from CEO Mårten Hellbergs comments to the

Ratos company SSEA Group acquires Kiruna Målbygg AB

The Ratos company SSEA Group, which opened an office in Luleå earlier this year, is further strengthening its presence in northern Sweden by acquiring the local construction and painting company Kiruna Målbygg.Kiruna Målbygg AB is a profitable construction and painting company with 22 employees. The company has sales of SEK 28m (2021) and carries out construction and painting assignments in Kiruna and the surrounding area. The company has framework agreements in place with various property owners, including Kirunabostäder and LKAB Fastigheter. Kiruna Målbygg AB was founded in 2001.“As the

Invitation to Scandion Oncology webcast and conference call November 16, 2022

Scandion Oncology (Scandion), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options, will publish its Q3 2022 interim report on Wednesday November 16, 2022, before 09:00 CET. Scandion’s Executive Management will host a webcast and conference call the same day at 10:00 CET presenting the results and a company update. At the end of the presentation there will be a Q&A session.Access to the event can be obtained as follows: LIVE access on Wednesday November 16, 2022, at 10:00 CET Webcast: https://

Interim report January – September 2022

The period in summary Third quarter July 1 – September 30, 2022 –      On July 20th, 2022 Intervacc announced that the company had received an order for the equivalent of approximately SEK 3 million from Dechra Pharmaceuticals PLC. The order concerns delivery of Strangvac vials to be used for launch in selected European countries. –      On August 17 we announced that Strangvac began being sold in the UK, which is expected to be a significant country for the vaccine. –      CEO Andreas Andersson and three other key persons have subscribed for 330,455 shares in Intervacc by

Implantica Presents RefluxStop’s Health Economic Impact at ISPOR Europe 2022

Implantica AG (publ.), a MedTech company at the forefront of bringing advanced technology into the body, attended the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference Europe 2022 that was held 6-9 November, in Vienna, Austria and Virtual #ISPOREurope. ISPOR is the leading European conference for Health Economics and Outcomes Research (HEOR) held for discussion and dissemination of the latest trends in healthcare.ISPOR is recognized globally as the leading scientific and educational organization for health economics and outcomes research (HEOR) and it is

CO2 Capsol – Q3 2022 Results

Oslo, Norway - 10 November 2022CO2 Capsol´s Q3 results for 2022 was published today, 10 November 2022.The company reached several key milestones during the quarter:• The company signed a license agreement with Stockholm Exergi. Revenues due atproject Final Investment Decision, expected in 2023/24.• Q3 marks the first quarter with revenue. The company recognised revenues fromproject engineering work and from CapsolGo™ operations.• The first CapsolGo™ demonstration unit was delivered on time and on budget. Itwas commissioned at Öresundskraft´s Energy-from-Waste plant in

TORM plc delivers best quarterly result on record

In the third quarter of 2022, TORM achieved TCE rates of USD/day 44,376 (2021, same period: USD/day 12,854) with an EBITDA of USD 262m and a profit before tax of USD 217m. “Thanks to a strong market, TORM achieved the best quarterly results on record during the third quarter of 2022,” says Executive Director Jacob Meldgaard, and continues “I am pleased that our healthy cash generation will enable us to distribute [USD 119m] in dividends to our shareholders; the highest quarterly distribution in TORM’s history”. Please see attached Q3 2022 report. Conference call and webcast TORM’

BioStock: Respiratorius marches towards partnering deal

Things are heating up for the development company Respiratorius and its drug candidate VAL001. Step by step, a potential partnering deal is getting closer and expectations are in the air. These expectations can also be felt when the company publishes its Q2 report for the fiscal year 2022/2023. BioStock contacted CEO Johan Drott to find out more.Read the full article at biostock.se: https://www.biostock.se/en/2022/11/respiratorius-marches-towards-partnering-deal/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Q3 2022 Interim Financial Report: high-inflation environment continued to drive price increases, while market demand started to soften

H+H International AS Q3 2022 Interim Financial Report Today, the Board of Directors of H+H International A/S (hereinafter referred to as “H+H” or “the Company”) has adopted the Interim Financial Report for the third quarter (“Q3 2022”) and the first nine months of 2022 (“Q3 2022”). CHIEF EXECUTIVE OFFICER JÖRG BRINKMANN QUOTE I’m very excited to join H+H and to be part of the highly committed organisation. I am pleased to see the benefits of the agile business model and how H+H is capable to offset the continued inflationary pressure with sales price increases and taking advantage

Notice to the Extraordinary General Meeting of Citycon Oyj

Citycon Oyj   Stock Exchange Release   10 November 2022 at 9:05 hrsThe Extraordinary General Meeting (the “General Meeting”) of Citycon Oyj will be held on Thursday, 8 December 2022 at 12:00 noon. The meeting will be held under special arrangements without shareholders’ or their proxy representatives’ presence at the headquarters of Citycon Oyj, at the address Piispansilta 9 A, FI-02230 Espoo, Finland.The Board of Directors of Citycon Oyj has resolved on exceptional meeting procedures based on the transitional provision enacted in connection with the changes (660/2022) to Chapter 5 of the

Investment decision for the Wisting project postponed

The partners in the Wisting licenses have decided to postpone the investment decision originally scheduled for December 2022. The maturation of the project continues, aiming for an investment decision by the end of 2026. CEO of Aker BP, Karl Johnny Hersvik comments:  "The Wisting partners, led by the operator Equinor, have matured a development concept for the Wisting field which is technically feasible and environmentally safe. However, in the current context of cost pressure and potential capacity constraints in the supply industry, combined with proposed changes in the temporary

Angler Gaming plc: Interim Report for 3rd Quarter 2022

22,6% sequential quarterly revenue growth and positive EBIT of €740,675 in Q3Key Facts for the 3[rd] Quarter 2022 (1[st] July 2022 – 30[th] September 2022) All figures are compared to the same quarter last year if not explicitly stated otherwise · Revenues decreased by 16.16% to €8,495,464 (€10,132,959) · EBIT of €740,675 (€2,112,089) · EBIT margin of 8.72% (20.84%) · Customer deposits decreased by 23.94% to €16,690,028 (€21,941,853) · 50,684 new registered customers (54,046), decrease of 6.22%. · 13,562 new depositing customers (19,584), decrease of 30.75%. ·

Metsä Board hosts a Capital Markets Day today in Helsinki

Metsä Board Corporation Investor News 10 November 2022Metsä Board, part of Metsä Group, will organise a Capital Markets Day for investors and analysts today, 10 November 2022 in Helsinki from 14:00 to 17:00 EET. The event, held in English, can also be followed online via webcast. Questions to the management can be submitted via webcast throughout the whole event. A recording of the event can be viewed afterwards on the company's website. A link to webcast and registration: https://metsaboard.videosync.fi/2022-cmd/register The day’s agenda will include an update on Metsä Board's

Interim Report January–September 2022

Proactive in an uncertain environmentJohn Mattson’s strong growth continued through the first three quarters of the year. Income from property management growth per share amounted to 58%. Adjusted for non-recurring items in 2021, growth was 47%. Growth in net asset value (NAV) per share was 14%. Consolidation of the company continues and John Mattson has implemented measures to address the new market conditions.  “John Mattson continues to deliver growth and stable property values. The company’s property portfolio, with housing in attractive locations in the Stockholm region, remains

Interim report January – September 2022

HIGHER NET SALES BUT LOWER VOLUMES – CONTINUED CHALLENGING MARKETJULY– SEPTEMBER 2022 · Sales volume amounted to 3,817 tonnes (4,862 tonnes) a decline by 21%. · Net sales amounted to SEK 232.0 million (SEK 222.0 million), an increase by 5%. The organic increase was 1%. · Operating profit amounted to SEK 10.8 million (SEK 24.7 million), a decline by 56%. The adjusted operating profit amounted to SEK 12.0 million (SEK 24.8 million), a decline by 52%. · The operating margin declined to 4.7% (11.1%) and adjusted operating margin declined to 5.2% (11.2%). · Profit for the period

Humana reports third quarter and nine-month 2022 results

Continuous improvements and profitable growth Third quarter, July–September 2022 · Operating revenue amounted to SEK 2,373 million (2,034), an increase of 16.7 percent mainly due to acquisitions in Sweden and Finland from prior periods, but also higher occupancy in underlying operations. · Organic growth was 4.0 percent (3.0). All business areas, except Personal Assistance, are contributing. The largest contribution came from Elderly Care and Individual & Family. · Operating profit amounted to SEK 171m (192), a decrease of 10.9 percent. The decrease is mainly due to increased

Acroud publishes interim report Jul-Sep 2022: Another piece in Acroud's transformation

Financial highlights during third quarter 2022   · Revenue amounted to EUR 6 683 (6 448) thousand, corresponding to a growth of 4% and an organic growth of 2.1%.    · EBITDA amounted to EUR 1 496 (1 258) thousand, increasing by 19% year-on-year.    · Profit after tax was EUR -589 (593) thousand. Adjusted profit after tax (before items affecting comparability and currency effects) was EUR -188 (482) thousand.   · Earnings per share after dilution amounted to EUR -0.005 (0.005). Adjusted earnings per share (before items affecting comparability and currency

Citycon’s Financial Reporting Schedule and AGM in 2023

CITYCON OYJ   Stock Exchange Release   10 November 2022 at 09:00 hrsCitycon Oyj’s schedule of the financial reporting in 2023 is the following: Year 2022 full-year Financial Thursday 16 February 2023 after market closeReport, Financial Statements andthe Report by the Board ofDirectorsYear 2023 three-month Interim Thursday 4 May 2023 after market closeReportYear 2023 six-month Half-Yearly Tuesday 18 July 2023 after market closeReportYear 2023 nine-month Interim Wednesday 1 November 2023 after market closeReport Citycon Oyj’s Annual General Meeting (AGM)

Citycon Oyj´s Interim Report for 1 January-30 September 2022: Continued NRI growth and reaffirming full year guidance

Citycon Oyj   Interim Report   10 November 2022 at 09:00 hrsSTRONG OPERATIONAL PERFORMANCE · Like-for-like net rental income in Q3 increased 3.4% compared to the previous year · Year-to-date, LFL net rental income increased 5.2% · Standing net rental income in Q3 increased in 5.3% and year-to-date 7.8% · Like-for-like footfall in Q3 increased 4.3% and year-to-date 12.1% · Like-for-like tenant sales in Q3 increased 0.1%; 7.9% higher than the same period in Q3/2019 (pre-pandemic level) · Year-to-date, like-for-like tenant sales increased 7.0% compared to previous year

Fortum’s January–September 2022 Interim Report: A watershed quarter – Fortum divests Uniper and refocuses on securing supply with clean power in the Nordics

FORTUM CORPORATION JANUARY–SEPTEMBER 2022 INTERIM REPORT 10 NOVEMBER 2022 AT 9:00 EET This release is a summary of Fortum’s January–September 2022 Interim Report. The complete report is attached to this release as a PDF file. It is also available on the company's website at www.fortum.com/investors. July–September 2022, continuing operations · Comparable EBITDA was EUR 561 (386) million · Comparable operating profit was EUR 421 (243) million · Operating profit was EUR 917 (3,000) million, mainly impacted by changes in fair values of non-hedge-accounted derivatives. In the

World-first: Volvo delivers electric trucks with fossil-free steel to customers

As the world’s first truck manufacturer to do so, Volvo has begun using fossil-free steel in its trucks. The first electric trucks with fossil-free steel are now being delivered to customers.In September this year, Volvo Trucks started series production of heavy-duty electric, 44 tonne* trucks, as the first global truck manufacturer to achieve this. Some of the electric trucks will also be the first trucks in the world that are built with fossil-free steel. “Our journey to net zero emissions includes both making our vehicles fossil free in operation and over time fully replacing the

There are no items matching the current filter
There are no more items matching the current filter
Back to top